Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:zgnx | https://www.glassdoor.com?employer_id=100281 | 100281 | Apr 21st, 2024 12:00AM | Open | Zogenix | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2006 | 3.30 | 79% | 46% | 53% | 3.80 | 3.80 | 3.20 | 4.50 | 3.70 | 3.20 | 1.00 | 1.00 | 3.00 | 5.00 | 11.00 | 13.00 | 20% | 20% | 60% | 0.00 | 0.00 | 32.00 | 0.75 | 0.25 | 0.40 | 0.30 | 0.20 | 0.10 | Stephen Farr, Ph.D. | Apr 21st, 2024 04:34PM | Apr 21st, 2024 04:34PM | Zogenix | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||
nasdaq:zgnx | https://www.glassdoor.com?employer_id=100281 | 100281 | Apr 20th, 2024 12:00AM | Open | Zogenix | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2006 | 3.30 | 79% | 46% | 53% | 3.80 | 3.80 | 3.20 | 4.50 | 3.70 | 3.20 | 1.00 | 1.00 | 3.00 | 5.00 | 11.00 | 13.00 | 20% | 20% | 60% | 0.00 | 0.00 | 32.00 | 0.75 | 0.25 | 0.40 | 0.30 | 0.20 | 0.10 | Stephen Farr, Ph.D. | Apr 20th, 2024 04:49PM | Apr 20th, 2024 04:49PM | Zogenix | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||
nasdaq:zgnx | https://www.glassdoor.com?employer_id=100281 | 100281 | Apr 19th, 2024 12:00AM | Open | Zogenix | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2006 | 3.30 | 79% | 46% | 53% | 3.80 | 3.80 | 3.20 | 4.50 | 3.70 | 3.20 | 1.00 | 1.00 | 3.00 | 5.00 | 11.00 | 13.00 | 20% | 20% | 60% | 0.00 | 0.00 | 32.00 | 0.75 | 0.25 | 0.40 | 0.30 | 0.20 | 0.10 | Stephen Farr, Ph.D. | Apr 19th, 2024 07:47AM | Apr 19th, 2024 07:47AM | Zogenix | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||
nasdaq:zgnx | https://www.glassdoor.com?employer_id=100281 | 100281 | Apr 18th, 2024 12:00AM | Open | Zogenix | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2006 | 3.30 | 79% | 46% | 53% | 3.80 | 3.80 | 3.20 | 4.50 | 3.70 | 3.20 | 1.00 | 1.00 | 3.00 | 5.00 | 11.00 | 13.00 | 20% | 20% | 60% | 0.00 | 0.00 | 32.00 | 0.75 | 0.25 | 0.40 | 0.30 | 0.20 | 0.10 | Stephen Farr, Ph.D. | Apr 18th, 2024 06:09PM | Apr 18th, 2024 06:09PM | Zogenix | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||
nasdaq:zgnx | https://www.glassdoor.com?employer_id=100281 | 100281 | Apr 17th, 2024 12:00AM | Open | Zogenix | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2006 | 3.30 | 79% | 46% | 53% | 3.80 | 3.80 | 3.20 | 4.50 | 3.70 | 3.20 | 1.00 | 1.00 | 3.00 | 5.00 | 11.00 | 13.00 | 20% | 20% | 60% | 0.00 | 0.00 | 32.00 | 0.75 | 0.25 | 0.40 | 0.30 | 0.20 | 0.10 | Stephen Farr, Ph.D. | Apr 17th, 2024 02:36PM | Apr 17th, 2024 02:36PM | Zogenix | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||
nasdaq:zgnx | https://www.glassdoor.com?employer_id=100281 | 100281 | Apr 16th, 2024 12:00AM | Open | Zogenix | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2006 | 3.30 | 79% | 46% | 53% | 3.80 | 3.80 | 3.20 | 4.50 | 3.70 | 3.20 | 1.00 | 1.00 | 3.00 | 5.00 | 11.00 | 13.00 | 20% | 20% | 60% | 0.00 | 0.00 | 32.00 | 0.75 | 0.25 | 0.40 | 0.30 | 0.20 | 0.10 | Stephen Farr, Ph.D. | Apr 16th, 2024 10:48AM | Apr 16th, 2024 10:48AM | Zogenix | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||
nasdaq:zgnx | https://www.glassdoor.com?employer_id=100281 | 100281 | Apr 15th, 2024 12:00AM | Open | Zogenix | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2006 | 3.30 | 79% | 46% | 53% | 3.80 | 3.80 | 3.20 | 4.50 | 3.70 | 3.20 | 1.00 | 1.00 | 3.00 | 5.00 | 11.00 | 13.00 | 20% | 20% | 60% | 0.00 | 0.00 | 32.00 | 0.75 | 0.25 | 0.40 | 0.30 | 0.20 | 0.10 | Stephen Farr, Ph.D. | Apr 15th, 2024 05:10PM | Apr 15th, 2024 05:10PM | Zogenix | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||
nasdaq:zgnx | https://www.glassdoor.com?employer_id=100281 | 100281 | Apr 14th, 2024 12:00AM | Open | Zogenix | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2006 | 3.30 | 79% | 46% | 53% | 3.80 | 3.80 | 3.20 | 4.50 | 3.70 | 3.20 | 1.00 | 1.00 | 3.00 | 5.00 | 11.00 | 13.00 | 20% | 20% | 60% | 0.00 | 0.00 | 32.00 | 0.75 | 0.25 | 0.40 | 0.30 | 0.20 | 0.10 | Stephen Farr, Ph.D. | Apr 14th, 2024 10:48AM | Apr 14th, 2024 10:48AM | Zogenix | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||
nasdaq:zgnx | https://www.glassdoor.com?employer_id=100281 | 100281 | Apr 13th, 2024 12:00AM | Open | Zogenix | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2006 | 3.30 | 79% | 46% | 53% | 3.80 | 3.80 | 3.20 | 4.50 | 3.70 | 3.20 | 1.00 | 1.00 | 3.00 | 5.00 | 11.00 | 13.00 | 20% | 20% | 60% | 0.00 | 0.00 | 32.00 | 0.75 | 0.25 | 0.40 | 0.30 | 0.20 | 0.10 | Stephen Farr, Ph.D. | Apr 13th, 2024 11:17AM | Apr 13th, 2024 11:17AM | Zogenix | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||
nasdaq:zgnx | https://www.glassdoor.com?employer_id=100281 | 100281 | Apr 12th, 2024 12:00AM | Open | Zogenix | Open | Company - Public | Biotech & Pharmaceuticals | Emeryville, CA | 2006 | 3.30 | 79% | 46% | 53% | 3.80 | 3.80 | 3.20 | 4.50 | 3.70 | 3.20 | 1.00 | 1.00 | 3.00 | 5.00 | 11.00 | 13.00 | 20% | 20% | 60% | 0.00 | 0.00 | 32.00 | 0.75 | 0.25 | 0.40 | 0.30 | 0.20 | 0.10 | Stephen Farr, Ph.D. | Apr 12th, 2024 08:17AM | Apr 12th, 2024 08:17AM | Zogenix | Health Care | Pharmaceuticals & Biotechnology |